Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

Alexander M. Menzies; Rodabe N. Amaria; Elisa A. Rozeman; Alexander C. Huang; Michael T. Tetzlaff; Bart A. van de Wiel; Serigne Lo; Ahmad A. Tarhini; Elizabeth M. Burton; Thomas E. Pennington; Robyn P.M. Saw; Xiaowei Xu; Giorgos C. Karakousis; Paolo A. Ascierto; Alexander C.J. van Akkooi; Michael A. Davies; Tara C. Mitchell; Hussein A. Tawbi; Richard A Scolyer; Jennifer A. Wargo; Christian U. Blank; Georgina V. Long

doi:10.1038/s41591-020-01188-3

Article2019

Pathological response and survival with neoadjuvant therapy in melanoma: A pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

Alexander M. Menzies, Elisa A. Rozeman, Rodabe Navroze Amaria, Alexander C. Huang, Richard A Scolyer, Michael T. Tetzlaff, Bart A. van de Wiel, Serigne Lo, Ahmad A. Tarhini, Hussein Tawbi, Elizabeth M. Burton, Giorgos C. Karakousis, Paolo A. Ascierto, Andrew J. Spillane, Michael A. Davies, Alexander Christopher Jonathan Van Akkooi, Tara C. Mitchell, Georgina V. Long, Jennifer A. Wargo, Christian U. Blank

Article2024

LBA41 Long-term survival with neoadjuvant therapy in melanoma: Updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

G.V. Long, C.U. Blank, R. Amaria, Tina J. Hieken, Shahneen Sandhu, M.J. Barros, T.C.C. Mitchell, Zeynep Eroglu, Igor Samoylenko, P. Rutkowski, D.B. Johnson, I. Pires da Silva, Kyle A. Perry, H.A. Tawbi, Matthew S. Block, P.A. Ascierto, Eric Burton, Alexander C.J. van Akkooi, Richard A. Scolyer, A.M. Menzies

Article2017

Preliminary results from the international neoadjuvant melanoma consortium (INMC).

Alexander M. Menzies, Elisa A. Rozeman, Rodabe Navroze Amaria, Richard A Scolyer, Michael T. Tetzlaff, Alexander Guminski, Michael A. Davies, Christian U. Blank, Jennifer A. Wargo, Georgina V. Long

Article2022

Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

Alexander C.J. van Akkooi, Tina J. Hieken, Elizabeth M. Burton, Charlotte E. Ariyan, Paolo A. Ascierto, Salvatore Asero, Christian U. Blank, Matthew S. Block, Genevieve M. Boland, Corrado Caracò, Sydney Ch’ng, Bradley S. Davidson, João Pedreira Duprat Neto, Mark B. Faries, Jeffrey E. Gershenwald, Dirk J. Grünhagen, David Gyorki, Dale Han, Andrew Hayes, Winan J. van Houdt, Giorgos C. Karakousis, W. Martin C. Klop, ,

Corrigendum2022

Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

Alexander C.J. van Akkooi, Tina J. Hieken, Elizabeth M. Burton, Charlotte E. Ariyan, Paolo A. Ascierto, Salvatore Asero, Christian U. Blank, Matthew S. Block, Genevieve M. Boland, Corrado Caracò, Sydney Ch’ng, Bradley S. Davidson, João Pedreira Duprat Neto, Mark B. Faries, Jeffrey E. Gershenwald, Dirk J. Grünhagen, David Gyorki, Dale Han, Andrew Hayes, Winan J. van Houdt, Giorgos C. Karakousis, W. Martin C. Klop,

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

Discussion(0)

Related publications

Pathological response and survival with neoadjuvant therapy in melanoma: A pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

LBA41 Long-term survival with neoadjuvant therapy in melanoma: Updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

Preliminary results from the international neoadjuvant melanoma consortium (INMC).

Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)